{"doc_id": "bYg6ooZhRt", "title": "Matteo Calligaris - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/matteo-calligaris/", "lang": "en", "text": "Matteo Calligaris - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nMatteo Calligaris\nMatteo Calligaris\nName: Matteo Calligaris\nContacts\nTel. 091 6041480\ne-mail\nmatteo.calligaris@phd.unipi.it\nSupervisors\nProf. Elisa Nuti\nDr. Simone Scilabra\nPhD Project title\nStudying iRhom2 as new potential therapeutic target in Osteoarthritis\nResearch summary\nOsteoarthritis (OA) is an articular joint disease which affects 250 million people worldwide. Due to these numbers, it has notable implication on the healthcare system and wider economic impact. The pathogenesis of OA is complex and comprises mechanical, inflammatory, and metabolic factors, which ultimately lead to structural destruction and failure of the joint.\niRhom2 plays a pivotal role in inflammation by regulating TNF alpha release. It has been seen that ablating its activity results in an improvement in several inflammatory condition such as sepsis, rheumatoid arthritis, lupus nephritis and metabolic disorders.\nFrom our preliminary data, iRhom2 may control the function of proteins involved in the articular joint wreckage. We speculated that iRhom2 could be a potential therapeutic target for OA by tackling the disease from two different aspects: preventing chronic inflammatory condition and reducing joint degradation.\nTo fully understand the role of iRhom2 in the pathogenesis and development of the disease, the project relies on a highly collaborative network. The aims of my project are:\nProduce an inhibitor antibody using novel phage-display library (Nissim library) able to block iRhom2 activity and contrast OA development. This part of the project will be carried out at the Prof. Nissim lab at the William Harvey Research Institute at the Queen Mary University in London.\nUsing state-of-art bioinformatic tools to develop small molecules from positive candidate of phage-display inhibitory antibody and validate possible compound to transfer in clinic. This part of the project will be undertaken in Prof. Nuti lab at the Department of Pharmacy in Pisa who has already developed several bioactive compound important in the field of OA.\nUse cutting edge technique of shotgun proteomics and biochemistry to bring to light the mechanistic role of iRhom2 in joint degradation. This part of the project will be undertaken at the Fondazione Ri.MED in Palermo under the supervision of Dr. Scilabra.\nInvestigate OA development in surgical-induced mice model. This part of the project will be taken over at the Institute of Ageing and Chronic Disease at the University of Liverpool under the supervision of a leading researcher in the field of OA mouse model: Prof. Bou-Gharios.\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "KZfnrGABsL", "title": "Ylenia Pieracci - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/ylenia-pieracci/", "lang": "en", "text": "Ylenia Pieracci - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nYlenia Pieracci\nYlenia Pieracci\nName: Ylenia Pieracci\nContacts\n:\nPhone:\n050 221 9500\ne-mail: ylenia.pieracci@phd.unipi.it\nSupervisors\n: Professor Guido Flamini\nPhD project Title\n:\nChemical, biological and sensorial analyses in the agri-food and herbal sectors\nResearch summary\n:\nMy research project proposes the chemical analysis of volatile and non-volatile compounds along the production chain of food or herbal products, from the raw plant material to the final product, in order evaluate the correlation between chemical profile and both the adequacy of the critical phases of the supply chain and the quality of the final product.\nMoreover, the project includes the evaluation of the chemical profile of by-products, which are usually discarded from the agri-food system, with the purpose of finding new possible intended uses, reducing losses and waste. Today, this aspect is of great importance because the agri-food is one of the production sectors that generates the higher levels of losses and waste, all of which have economic, ecologic and social impact, and are key-components of the sustainability matter, more and more important as a tool to fight climate change.\nORCID:\nhttps://orcid.org/0000-0002-0993-7946\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "M8ajRbnite", "title": "Riccardo Di Leo - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/riccardo-di-leo/", "lang": "en", "text": "Riccardo Di Leo - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nRiccardo Di Leo\nRiccardo Di Leo\nName:\u00a0 \u00a0 \u00a0 \u00a0 Riccardo Di Leo\nContacts:\nphone: 0502219500\ne-mail:\ndileo@phd.unipi.it\nSupervisors:\nProfessor Armando Rossello\nPhD Project Title:\nDevelopment of new compounds for the diagnosis and treatment of infectious diseases\nResearch summary:\nMy PhD project consists of two parts. The first one deals with the development of inhibitors targeting thermolysin from\nPseudomonas aeruginosa\n. To identify new selective inhibitors of the pathogen virulence factor could be a new promising strategy for the discovery of antibacterial drugs with a low risk of resistance. This research is a part of the project HNF1514-20, funded by \u201cThe Research Council of Norway\u201d. The second part of my project is focused on the development of new antiviral compounds against the main protease\n(M\npro\n)\nof SARS-Cov-2. The design of new compounds will be developed in collaboration with the research group of Prof. Gerard Pujadas of Tarragona\u2019s University. Moreover, the research group of Prof. F. Xavier Gomis-R\u00fcth (IBMB, Barcelona) will produce the recombinant viral protein and will develop both inhibition HTS studies and RX complexation studies.\nORCID:\nhttps://orcid.org/0000-0002-5051-1584\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "Aq5Va7d25P", "title": "Brunella Grassiri - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/brunella-grassiri/", "lang": "en", "text": "Brunella Grassiri - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nBrunella Grassiri\nBrunella Grassiri\nName: Brunella Grassiri\nContacts\n:\nPhone: +39 3349753937\ne-mail:\nbrunella.grassiri@phd.unipi.it\nSupervisors\n: Prof. A.M. Piras\nPhD project Title\n: Development and assessment of innovative mucoadhesive functional excipients to overcome biopharmaceutical limitations of mucosal barriers.\nResearch summary\n: (max 1000 crt, spazi inclusi)\nToday, the pharmaceutical technology is steeply rising, both improving the effectiveness of actives and supporting the success of novel clinical therapies. The present doctorate project will be devoted to further improve the functional properties of pharmaceutical grade excipients in view of their application in local treatments of mucus protected tissues.\nThe research activities will focus on the role of mucoadhesive macromolecules on enhancing the bioavailability of both poorly soluble drugs and labile active molecules (i.e. proteins), with special interest on antimicrobial applications. The innovative aspects include: the modulation of mucus-adhesiveness by combining grafted\u00a0 cationic moieties and protected thiolation on macromolecular excipients such as cyclodextrins and chitosan; the use of microwave assisted synthetic approach suitable for scale up applications, and\u00a0 the exploitation of excipient intrinsic antimicrobial properties for a potentiated effect.\nORCID Author ID\n: 57221446066\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "V29xqxhSMN", "title": "Salvatore Galati - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/salvatore-galati/", "lang": "en", "text": "Salvatore Galati - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nSalvatore Galati\nSalvatore Galati\nName:\nSalvatore Galati\nContacts\n:\nPhone: +393407214531\ne-mail: salvatore.galati@phd.unipi.it\nSupervisors\n:\nProfessor Tiziano Tuccinardi\nPhD project Title\n:\nDevelopment of a reliable target fishing platform based on a consensus artifical intelligence approach\nResearch summary\n:\nMy PhD research areas majorly involve computational drug discovery using an artificial intelligence approach. Machine learning (ML) is the study of computer algorithms that improve automatically through experience. Machine learning algorithms build a mathematical model based on sample data, known as \u201ctraining data\u201d, in order to make predictions or decisions without being explicitly programmed to do so. Recently, there has been increasing interest in ML in many areas of science including pharmaceutical research. In the context of compound activity prediction, which is a core task in computational medicinal chemistry, this principle implies that some structural features and/or molecular properties should be common to active compounds, regardless of their targets. The aim of my project is to develop an innovative approach for virtual screening that can improve the limitation of current QSAR methods that fail to build a model for targets with few data.\nORCID\n:\n0000-0002-1959-5839\nSCOPUS\n:\nhttps://www.scopus.com/authid/detail.uri?authorId=57212506355\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "3Xf6gkhadW", "title": "Luca Campisi - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/luca-campisi/", "lang": "en", "text": "Luca Campisi - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nLuca Campisi\nLuca Campisi\nName:\nLuca Campisi\nContacts\n:\nPhone: + 39 320 46 06 372\ne-mail: luca.campisi@phd.unipi.it\nSupervisors\n:\nProf. Concettina La Motta\nPhD project Title\n:\nEndocrine Disrupting Chemicals (EDCs): improving the current health risk assessment procedure through theoretical and experimental approaches.\nResearch summary\n: (max 1000 crt, spazi inclusi)\nThis project aims at improving the risk assessment procedure currently adopted for the endocrine disrupting chemicals (EDCs), focusing on those affecting thyroid homeostasis.\nMoving from the existing data and making use of both computational tools and in vitro and in vivo studies, a novel basic model will be developed, able to predict adverse thyroid effects caused by EDCs.\nEDCs generally display a complex toxicity profile, thus making toxicological evaluation and health risk assessment difficult to achieve. Actually, they may show varied and multiple mechanism of action, which can be also different between and within species.\nA so complex profile makes the current standardized test methods rather insufficient to identify and test the complex toxicity of EDCs, and the application of traditional risk assessment principles may be problematic in the case of EDCs.\nTherefore, novel approaches are needed to get to a reliable risk assessment that is protective for the entire population.\nORCID:\nhttps://orcid.org/0000-0001-5997-8458\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "F2oYn6heUh", "title": "Emma Baglini - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/emma-baglini/", "lang": "en", "text": "Emma Baglini - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nEmma Baglini\nEmma Baglini\nContacts\n:\nTel: 0502219500\ne-mail:\nemma.baglini@phd.unipi.it\nSupervisor:\nProf.ssa Sabrina Taliani\nPhD project Title:\nDesign and synthesis of novel small molecules as anticancer agents.\nResearch summary\n:\nMy research project is involved in the design and the synthesis of small molecules, with potential activity against several targets, all implicated in cancer. During the first year a small library of compounds was designed and synthesized. The compounds developed will be tested to prove their biological activity\nin vitro\n; once the biological results are obtained, the studies of the structure-activity relationships will allow to design further structural modifications aimed to increase the efficacy of the compounds. Then, various cycles of design, synthesis and biological evaluations will be reiterated, also combining the different point structural modifications that have produced the best results in terms of biological efficacy, with the final goal to obtain compounds endowed with an efficient antiproliferative activity against tumor cells.\nPoster communications at congress\n:\nTSPO density assessment in human glioma cell lines using the fluorescent ligand F-PIGA\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "Wpi6LmniYB", "title": "Anna Maria Iannuzzi - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/anna-maria-iannuzzi/", "lang": "en", "text": "Anna Maria Iannuzzi - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nAnna Maria Iannuzzi\nAnna Maria Iannuzzi\nContacts\n:\nTel: 0502219500\ne-mail:\nanna.iannuzzi@farm.unipi.it\nSupervisors:\nProf.ssa Alessandra Braca\nPhD project Title:\nBioprospecting of Mediterranean flora: researching natural products with medicinal and nutritional value\nResearch summary:\nThe subject of this research project is the phytochemical and biological study of endemic plants belonging to different families to exploit the biodiversity of Mediterranean flora following by a bioprospecting approach. Bioprospecting is \u201cthe search for plant and animal species from which medicinal drugs and other commercially valuable compounds can be obtained\u201d. According to this idea, the study of endemic plants in the continuous search for new herbal drugs, herbal preparations and food within the Mediterranean biodiversity is of pivotal importance to enhance and preserve this unique genetic resource, exploit its potential economic value and improve human well-being. The experimental steps of the project include the selection of plants of Mediterranean area, belonging to different genus for their chemotaxonomic, phylogenetic, traditional, and medicinal features; the extraction of plant material with solvents of different polarity; the isolation of active constituents by chromatographic processes such as HPLC, CPC, GC, flash chromatography, gel filtration chromatography; the chemical characterization of the isolated compounds using NMR, MS and UV techniques; and the evaluation of their biological activity, as leads for the design of new drugs.\nPublications\n:\nOral communications at congress\n:\nAnna Maria Iannuzzi>, Alessandra Braca, Chiara Sinisgalli, Marinella De Leo, Luigi Milella, Angela Ostuni, Sergio Giani, Rokia Sanogo.\nAdansonia digitata\nL. (Baobab) from Mali: Phytochemical profile, antioxidant and antidiabetic activities of its fruit pulp and leaves. XVI Congress of the Italian society of Phytochemistry jointly 2\nnd\nInternational Congress on Edible, Medicinal and Aromatic Plants (ICEMAP 2019). Alghero, June 19-21, 2019.\nPoster communications at congress:\nAnna Maria Iannuzzi, C\u00e9sar Munoz Camero, Khadidja Aya Beladjila, Marinella De Leo, Valeria D\u2019Angelo, Maria Pala German\u00f2, Smain Amira, Ammar Bader, Nunziatina De Tommasi, Alessandra Braca. Antiangiogenic activity of iridoids from Lamiaceae and Plantaginaceae species. 67\nth\nInternational Congress and Annual meeting of the Society for Medicina plant and Natural Product Research (GA) in cooperation with the French Society of Pharmacognsy AFERP. Innsbruck, Austria, September 1-4, 2019, p. 311, PO-368.\nAnna Maria Iannuzzi, Fabiano Camangi, Marinella De Leo, Alessandra Braca, Nunziatina De Tommasi. Phytochemical profile of Cornus sanguinea L. fruit. 114\u00b0 congresso della Societ\u00e0 Botanica Italiana.VI international plant science conference (IPSC). Padova, September 4-6, 2019, p. 114, PO-168.\nM. Iannuzzi, M. De Leo, A. Braca. Chemical profile of wild and cultivated Salsola soda aerial parts. The 66\nth\nAnnual Meeting of the Society for Medicinal Plant and Natural Product Research jointly with the 11\nth\nShanghai International Conference on Traditional Chinese Medicine and Natural Medicine, Shanghai, China, 26-29 August 2018, p. 88-89, PO-72.\nGuillen Huallpa, A. M. Iannuzzi, M. De Leo, N. De Tommasi, C. Granchi, A. Braca. Clerodanes from Salvia pseudorosmarinus and their activity as inhibitors of monoacylglycerol lipase (MAGL). The 66\nth\nAnnual Meeting of the Society for Medicinal Plant and Natural Product Research jointly with the 11\nth\nShanghai International Conference on Traditional Chinese Medicine and Natural Medicine, Shanghai, China, 26-29 August 2018, p. 100-101, PO-88.\nDe Leo, F. Camangi, B. Muscatello, A. M. Iannuzzi, C. Giacomelli, F. Graziani, M. L. Trincavelli, C. Martini, A. Braca. Phytochemical analysis and antisenescence activity of Sorbus torminalis (L.) Crantz and Elaeagnus umbellata Thunb fruits. 113\u00b0 Congresso della Societ\u00e0 Botanica Italiana V International Plant Science Conference, Fisciano (SA), 12-15 September 2018, CO17, p.51.\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "4HFuP9GK64", "title": "Claudio Federghini - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/claudio-federghini/", "lang": "en", "text": "Claudio Federghini - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nClaudio Federghini\nClaudio Federghini\nContacts\n:\nTel: 0502219500\ne-mail:\nclaudioferdeghini@gmail.com\nSupervisors\n:\nProf. Christian Silvio Pomelli\nPhD project Title:\nSemi-rigid Task Specific Dicationic Ionic Liquids as artificial enzymes and drug delivery systems\nResearch summary:\nEnzyme-catalyzed reactions are of great interest and found useful applications in bioorganic and pharmacologic fields. It has been reported that the use of non-aqueous solvents less polar than water has beneficial effect upon several aspects of an enzymatic reaction such as for instance the solubility of reagents/products, their hydrolysis and the recovery of the biocatalyst. Ionic liquids are organic salts obtained by the combination of an organic cation and an anion which can be of organic or inorganic nature. Their potential in chemical sciences has been explored and led to interesting applications such as their use as solvents for high temperature organic synthesis, zeolite synthesis, biomass conversion, cellulose dissolution, dye-sensitized solar cells preparations, and CO\n2\ncapture. They are also used in metal and enzymatic reactions as their properties can be finely tuned by changing the cation or the anion to optimize the efficiency of a reaction. Even if they are usually employed as solved or co-solvent, some ionic liquids have already been used as catalyst of organic reactions. Chloroaluminate(III) ionic liquids, for example, have been successfully employed for electrophilic substitutions, Friedel-Crafts acylations, olefin dimerizations and olefin hydrogenations. Dicationic ionic liquids (DILs) are a new class of ionic liquids that possess two head groups (cationic sites) linked by a spacer, either rigid or fairly flexible. DILs present valuable advantages over the monocationic ionic liquids, like higher thermal stability and lower critical micelle concentration (CMC) values. Due to their properties, their applications span from lubrication to organic synthesis. Dicationic ionic liquids have unique structures that allow them to be selective for certain types of compounds. This property was already efficiently exploited to separate aromatics from aliphatic compounds.\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "WvYHXRjSLJ", "title": "Lorenzo Germelli - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/lorenzo-germelli/", "lang": "en", "text": "Lorenzo Germelli - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nLorenzo Germelli\nLorenzo Germelli\nContacts\n:\nTel: 0502219500\ne-mail:\nlorenzo.germelli@phd.unipi.it\nSupervisors\n:\nProf Eleonora Da Pozzo\nPhD project Title\n:\nStudy of TSPO in human glial cells as possible target for control of neuroinflammation\nResearch summary\n:\nNeuroinflammation is a biological process closely related to the onset of neurodegenerative diseases. During this process, glial cells exert a pivotal role in control of neuroinflammation but, at the same time, their activation can lead to an aggravation of the pathological conditions. TSPO (18 kDa Translocator Protein) is an outer mitochondrial membrane protein involved in various cellular processes such as proliferation, apoptosis and steroidogenesis. In the central nervous system TSPO is particularly expressed in glial cells, thereby it has been proposed as a novel target for the control and even imaging of neuroinflammation. However, its real role in neuroprotection has raised many controversies in years, especially about its involvement in steroidogenesis\n\u201cde novo\u201d\n. The purpose of my PhD project will focus on the evaluation of the effective role of TSPO in steroidogenesis and in particular if the production of steroids can bring to an anti-inflammatory phenotype shift of microglial cells. In addition, my work will focus on how TSPO is regulated during neuroinflammation, so the cellular pathways involved.\nPublications\n:\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "n5VKMPALtB", "title": "Rebecca Piccarducci - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/rebecca-piccarducci/", "lang": "en", "text": "Rebecca Piccarducci - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nRebecca Piccarducci\nRebecca Piccarducci\nContacts\n:\nTel: 0502219564\ne-mail:\nrebecca.piccarducci@farm.unipi.it\nSupervisors\n:\nProf. Claudia Martini, Prof. Simona Daniele\nPhD project Title\n:\nSignal pathways in brain aging and neurodegenerative disorders.\nResearch summary\n:\nMy Ph.D. project focuses on signal pathways in brain aging and neurodegenerative disorders. Particular attention has been given to the misfolded proteins\u2019 structure and accumulation, which characterize these pathologies. Peripheral synuclein hetero-aggregates have been studied in healthy subjects and patients affected by Alzheimer\u2019s Disease and Parkinson\u2019s Disease. Moreover, the project includes the study of amyloid proteins and amyloidosis, in collaboration with the University College of London (Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine of Royal Free Campus \u2013 London, UK), where I spent a research abroad period (February \u2013 July 2019). The investigation of the proteasome system, implicated in the degradation of misfolded proteins, and initially investigated in brain cancer cells, is a pivotal point of the project.\nPublications\n:\nOral communications at congress\n:\nPiccarducci, S. Daniele, F. Baldacci, D. Pietrobono, L. Giampietri, M. L. Trincavelli, G. Siciliano, R. Ceravolo, G. Tognoni, U. Bonuccelli, C. Martini. \u03b1-synuclein heterocomplexes in red blood cells as potential diagnostic biomarkers in Alzheimer\u2019s Disease. Riunione nazionale \u201cA. Castellani\u201d dei Dottorandi di Ricerca in Discipline Biochimiche, 2019, 3-7 June, Brallo di Pregola, Italy.\nOral comunication.\nPiccarducci, S. Daniele, D. Pietrobono, L.L. Trincavelli, J. Fusi, F. Franzoni, C. Martini. Influence of APOE polymorphism and physical activity on the well-being of erythrocytes: antioxidant capability and cellular membrane assessment. XV FISV Congress, 2018, 18-21 September, Rome, Italy. Oral comunication.\nPoster communications at congress\n:\nPiccarducci, S. Daniele, J. Fusi, F. Baldacci, U. Bonuccelli, F. Franzoni, C. Martini. Impact of ApoE polymorphism and physical activity on well-being of erythrocytes: antioxidant capability and cellular membrane assessment. SIB 60\nth\nCongress, 2019, 18-20 September, Lecce, Italy.\nFlash talk and poster.\nPiccarducci, S. Daniele, D. Pietrobono, C. Pellegrini, M. Fornai, L. Antonioli, C. Blandizzi, M.L. Trincavelli, C. Martini. Inflammation and \u03b1-synuclein heterocomplexes as biomarker of Alzheimer\u2019s disease: preliminary study in senescence accelerated mice. Out of the box research on neurodegeneration \u2013 Workshop, 2018, 3 December, Pisa, Italy.\nFlash talk and poster.\nPiccarducci, D. Pietrobono, C. Pellegrini, S. Daniele, M. Fornai, C. Blandizzi, M. L. Trincavelli, C. Martini. Inflammation and \u03b1-synuclein heterocomplexes in erythrocytes of an animal model of Alzheimer\u2019s Disease. More than neurons, 2018, 30 November-1 December, Torino, Italy.\nPoster.\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "THNDDkEKAA", "title": "Andrea Bacci - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/andrea-bacci/", "lang": "en", "text": "Andrea Bacci - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nAndrea Bacci\nAndrea Bacci\nContacts\n:\nTel: 050 2219582\ne-mail:\nandrea.bacci@phd.unipi.it\nSupervisors\n:\nProf. Simona Rapposelli\nPhD project Title\n:\nDesign and synthesis of novel dual BTK-TCL1 inhibitors for the treatment of lymphoma\nResearch summary\n:\nTargeting of Bruton tyrosine kinase (BTK) has shown as a novel therapeutic approach for lymphoproliferative disorders, however, is observed a drug-resistance due the selection of tumour clones bearing a mutated BTK and activation of alternative signalling pathways such as AKT and NF-kB. All these pathways are also co-activated through the interaction with TCL1 (T-cell leukemia/lymphoma 1), an important and so-far \u201cundruggable\u201d protein. A multi-target approach, aimed at obtain a simultaneous inhibition of both proteins with a single compound, could represent an innovative strategy for the treatment of lymphoma and an opportunity for preventing drug-resistance mechanisms. The aim of this project is to design and synthetize dual BTK-TCL1 inhibitors able to directly act against the mutated BTK forms but also against the AKT and NF-kB pathway activation, indirectly mediated by TCL1.\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "yHCisySuy7", "title": "Deborah Pietrobono - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/deborah-pietrobono/", "lang": "en", "text": "Deborah Pietrobono - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nDeborah Pietrobono\nDeborah Pietrobono\nContacts\n:\nTel: 0502219500\ne-mail:\ndeborah.pietrobono@farm.unipi.it\nSupervisors\n:\nProf.ssa Maria Letizia Trincavelli\nPhD project Title\n:\nSystem\u00a0Biology:\u00a0studying\u00a0molecular\u00a0pathways\nResearch summary\n:\nGlioblastoma multiforme (GBM) is an aggressive and invasive brain tumour, with a high mortality rate. The therapeutic treatment usually consists of surgical resection, followed by radiotherapy and the administration of the alkylating agent Temozolomide. Significant intra- and inter-tumour heterogeneity has been associated to aberrations in different intracellular pathways and a peculiar tumour microenvironment (TME) that contributes greatly to GBM progression. Among the different intracellular pathways, the deregulation of the oncosuppressor protein p53 and the reactivation of its endogenous function represents an important tool in GBM treatment. The p53 function might be impaired by multiple mechanisms such as the overexpression of its primary cellular inhibitor, the Murine Double Minute 2 protein (MDM2) promoting tumour proliferation. TME consists of diverse stromal cell types such as endothelial cells, astrocytes, microglia, glioblastoma associated macrophages (GAMs), glioblastoma associated fibroblast (TAFs), mesenchymal stem cells (MSCs), and extracellular factors. Adenosine (ADO) is one of the several extracellular factors in the TME. Under physiological conditions, extracellular adenosine levels remain in nanomolar range and increase up to 100 times during inflammation, hypoxia, or tumour formation. The role of extracellular ADO in GBM is still unclear. Some literature data reported that ADO plays a prominent role in GBM pathogenesis, growth, angiogenesis and invasiveness. The aim of my PhD project will be to investigate the intracellular molecular pathways involved in the pathogenesis of GBM and the impact of TME on its aggressive traits.\nPublications\n:\nOral communications at congress\n:\nPietrobono D, Giacomelli C, De Leo M, Daniele S, Bertoli A, Braca A, Trincavelli ML, Martini C. Human glioblastoma cell apoptosis is induced by Rosemary officinalis through the p53 functional reactivation. \u201cBio-energetics, Metabolism and Nutrition: from molecules to systems. Bio-energetica, Metabolismo e Nutrizione: dalle molecole ai sistemi \u2013 Meeting annuale dei Gruppi Membrane, Nutrizione e Biologia computazionale e dei sistemi della SIB. Bologna 2018, 25-26 June.\nPietrobono D, Trincavelli ML. Modulazione di vie di segnale coinvolte nei processi di apoptosi e invasivit\u00e0 del glioblastoma. Di nuovo TUM: mappatura interregionale delle tematiche SIB tra Toscana, Umbria e Marche, 2019, June 11, Ancona, Italy\nPoster communications at congress\n:\nPietrobono D, Piccarducci R, Giampietri L, Daniele S, Baldacci F, Nicoletti V, Frosini D, Petrozzi L, Trincavelli ML, Tognoni G, Bonuccelli U, Martini C. \u03b1-synuclein and its heterocomplexes significantly decrease in erythrocytes of Alzheimer\u2019s Disease patients. International conference, II edition, \u201cMore than neurons: toward a less neuronocentric view of brain disorders\u201d, Torino Incontra, Nov 29th-Dec 1st, 2018- Turin, Italy\nPietrobono D, Giacomelli C, Martini C, Trincavelli ML. Adenosine promotes glioblastoma aggressiveness modulating the epithelial-mesenchymal transition. 31a Riunione nazionale \u201cA. Castellani\u201d dei dottorandi di ricerca in discipline biochimiche 2019, June 3-7, Brallo di Pregola, Italy.\nPietrobono D, Daniele S, Parravicini C, Eberini I, Martini C, Trincavelli ML. Physical and functional interaction between GPR17 and the chemokine receptor 2: a promising tool for managing remyelination. First European Purine Meeting, 2019, 4-6 September, Santiago de Compostela, Spain.\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "sqtLkbkYMs", "title": "Giulia Bononi - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/giulia-bononi/", "lang": "en", "text": "Giulia Bononi - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nGiulia Bononi\nGiulia Bononi\nContacts\n:\nTel: 050 2219703\ne-mail:\ngiulia.bononi@phd.unipi.it\nSupervisors\n:\nProf. Filippo Minutolo, Prof. Carlotta Granchi\nPhD project Title\n:\nDevelopment of therapeutic and diagnostic agents targeting tumor lipid and sugar metabolism\nResearch summary\n:\nI am a PhD student in Medicinal Chemistry and my research project is focused on the development of therapeutic and diagnostic agents targeting tumor lipid and sugar metabolism. In particular, I am currently working on two projects: the first one concerns the design, synthesis and biological evaluation of new reversible inhibitors of monoacyglycerol lipase (MGL); the second one is focused on the design, synthesis and optimization of molecular probes which may be used for the imaging of glycolytic cancer cells.\nPublications\n:\nOral communications at congress\n:\nTUMA 2018 XXXVI Convegno interregionale (Pisa, October 4-5, 2018). Oral communication:\nBononi G.\n, Granchi C., Rizzolio F., Chicca A., Katzenellenbogen J. A., Tuccinardi T., Minutolo F. \u201cDiscovery and optimization of salicylketoxime derivatives as potent and reversible MAGL inhibitors\u201d.\nPoster communications at congress\n:\nCFF 2019 \u2013 Chemistry for the Future International Conference, (Pisa, July 3-5, 2019). Poster communication:\nG. Bononi\n, F. Rizzolio, A. Chicca, J. Katzenellenbogen, M. Macchia, T. Tuccinardi, C. Granchi, F. Minutolo. \u201cDesign and optimization of salicylketoximes as reversible and selective MAGL inhibitors\u201d.\nNMMC 2019 \u2013 XXVI National Meeting in Medicinal Chemistry and XII Young Medicinal Chemists\u2019 Symposium (Nuove Prospettive in Chimica Farmaceutica \u2013 NPCF12), (Milan, July 16-19, 2019). Poster communication:\nG. Bononi\n, F. Rizzolio, A. Chicca, J. Katzenellenbogen, M. Macchia, T. Tuccinardi, C. Granchi, F. Minutolo; \u201cSynthesis of ketoximic derivatives and their optimization as potent reversible MAGL inhibitors\u201d.\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "8fSRrbHbqB", "title": "Era Gorica - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/era-gorica/", "lang": "en", "text": "Era Gorica - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nEra Gorica\nEra Gorica\nContacts:\nTel: 0502219500\ne-mail:\nera.gorica@phd.unipi.it\nSupervisors:\nProf. Vincenzo Calderone\nPhD project Title:\n\u201cHydrogen Sulfide: role, therapeutic opportunities and development of novel pharmacological tools for vascular inflamm-aging and age-related cardiovascular diseases.\u201d\nResearch summary\n:\nCardiovascular diseases are the primary cause of death and disability in the elderly population, and aging is one of the most recognized risk factors in the development of these diseases (e.g., hypertension, myocardial infarction). In the last two decades, many studies have shown an increasing interest in endogenous gasotransmitters, especially in hydrogen sulfide (H2S). H2S is an endogenous mediator, involved in the regulation of several biological functions. Recent studies have described its important role in the regulation of cardiovascular homeostasis, and its deficiency is likely to be etiologically associated with several cardiovascular diseases. Therefore, the H2S supplementation by suitable H2S-donor molecules may be a promising pharmacological strategy. ITCs are sulfur secondary plant metabolites produced by several plants (e.g., broccoli, rocket salad, etc.) belonging to the Brassicaceae family. Over the past few years, their chemical function has been recognized as a suitable H2S-releasing moiety, and both natural and synthetic ITCs have been reported to exhibit the typical cardiovascular effects of H2S. To date, the vasorelaxing effects of aryl-ITCs have been described, and these effects have been attributed to the ability of H2S-release and thus to the triggering of H2S-mediated pathways, such as the activation of Kv7 potassium channels. As well, the vasorelaxing and antihypertensive activity of the natural ITC Erucin has been studied in experimental models of hypertension. Even the cardioprotective effects of ITCs have been evaluated in experimental models of cardiac ischemia/reperfusion and acute myocardial infarct. Ergo, the assessment of the cardiovascular effects of ITCs is a timely and challenging issue. This project aims to identify the pharmacological potential of natural ITCs in experimental models of cardiovascular inflamm-aging and age-related cardiovascular disorders.\nOral communications at congress\n:\nGorica E., Martelli A., Citi V., Piragine E., Brancaleone V., Di Cesare Mannelli L., Pagnotta E., Testai L., Ugolini L., Lazzeri L., Ghelardini C., Calderone V. Evaluation of anticancer properties of Erucin, the active principle of Eruca sativa Mill., on human pancreatic adenocarcinoma cells. Oral presentation at: Multidisciplinary Conference: \u201cChallenges in Health Care System\u201d. Tirana, Albania 04 April 2019 \u2013 06 April 2019.\nGorica E. PhD, what is behind the name? An Introduction to Doctoral Studies in Pharmaceutical Sciences. Student Informative Presentation at: Multidisciplinary Conference: \u201cChallenges in Health Care System\u201d. Tirana, Albania 04 April 2019 \u2013 06 April\n2019.\nGorica E., Martelli A., Citi V., Piragine E., Brancaleone V., Di Cesare Mannelli L., Pagnotta E., Testai L., Ugolini L., Lazzeri L., Ghelardini C., Calderone V. The H2S-donor Erucin promotes protective effects on endothelial and cardiac cells exposed to homocysteineinduced oxidative stress. Oral presentation at: International School of Pharmacology \u201cGiampaolo Velo\u201d. Erice, Sicily 08 September 2019 \u2013 12 September 2019.\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "QX3RvNE6qP", "title": "Rebecca Ferrisi - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/rebecca-ferrisi/", "lang": "en", "text": "Rebecca Ferrisi - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nRebecca Ferrisi\nRebecca Ferrisi\nContacts\n:\nTel: 050 2219566\ne-mail:\nrebecca.ferrisi@phd.unipi.it\nSupervisors\n:\nProfessor Clementina Manera\nPhD project Title\n:\nDesign, synthesis and biological evaluation of allosteric and bivalent ligands for novel strategies targeting G protein-coupled receptors\nResearch summary\n:\nMy PhD research project will focus on the following milestones:\nsynthesis of allosteric ligands\nsynthesis of bivalent ligands\nRegarding allosteric modulators, they have become relevant in the last decade as a new strategy to overcome the classical side effects due to the direct modulation of the orthosteric binding site. The allosteric ligands are able to induce conformational changes, modifying ligand affinity, functional efficacy and functional potency. They present several advantages such as higher receptor subtype and tissue selectivity, effect saturability and biased signaling towards orthosteric ligands which engage certain signaling interactions rather than other.\nRegarding bivalent ligands, I will focused on the synthesis of bitopic ligands, which simultaneously bind to the both allosteric and orthosteric site. This subclass of ligands exhibits the same advantages common to the allosteric ligands, but in addition provides a high affinity for the target GPCR and their effect occurs indipendently from the presence or absence of endogeneous tone.\nThe search of bivalent and allosteric ligands remains an important challenge also in relation to the endocannabinoid system. So, at the beginning, I\u2019ll have a special consideration for this interesting research field.\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "CppXEyP646", "title": "Chiara Tremolanti - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/chiara-tremolanti/", "lang": "en", "text": "Chiara Tremolanti - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nChiara Tremolanti\nChiara Tremolanti\nContacts\n:\nTel: 0502219500\ne-mail:\nchiara.tremolanti@phd.unipi.it\n;\nchiara.tremolanti@etu.unistra.fr\n.\nSupervisors\n:\nProfessor Barbara Costa; Professor Ayiko\u00e9, Guy Mensah-Nyagan.\nPhD project Title\n(\nJoint supervision of Doctoral thesis)\nNeuroprotection against abnormal myelination and neuroinflammation: role of TSPO-mediated regulations and genome editing based strategies against PLP mutation-induced oligodendrocyte death.\nResearch summary\n:\nMy PhD research project, to be developed in collaboration with the INSERM Unit 1119 \u2013 Biopathology of Myelin, Neuroprotection & Therapeutic strategies (University of Strasbourg), has the purpose of investigating the mechanisms involved in abnormal myelination and neuroinflammation underlying neurodegenerative and/or neurological disorders. In particular, the project will focus on the two following targets:\n(i) the mitochondrial\nTranslocator Protein\n18 kDa\n(\nTSPO\n);\n(ii) the major myelin\nProteolipid Protein (PLP)\n.\nDuring the first year of activity, I focused my research on the functional role of TSPO in immunomodulatory processes. Our published results are in favor of a homeostatic role for TSPO in the context of dynamic balance between anti-inflammatory and proinflammatory mediators in the human microglia-mediated inflammatory response. Our hypothesis is related to the steroidogenic activity of TSPO, and our future aim is to evaluate the effective steroids production by microglia cells. Besides, the study the regulation of TSPO gene transcription in inflamed glia cells will be performed, since its expression increases during the inflammation and returns to basal level when the phenomenon is resolved.\nOver the course of the 18 months at University of Strasbourg, I will be mainly focused on the modulations of PLP mutation and TSPO activity in oligodendrocytic and cell model of myelin disorders. Mutations of the major myelin protein PLP causes oligodendrocytes (OL) death, myelin abnormalities and neuronal dysfunctions leading to neurological disorders. First, we will study the effects of genome editing based strategies (CRISPR/Cas9) against PLP-mutation-induced OL death. Then, the modulation of TSPO neurosteroidogenic activity to counteract PLP-mutation-evoked OL death will be experimented. To determine TSPO-mediated actions, particularly the role of TSPO-induced neurosteroidogenesis in the control of OL activity and myelin formation, the project will investigate the effects of potent residence time-based selected TSPO ligands on OL life/survival, differentiation and myelinating activity.\nPublications\n:\nOral communications at congress\n:\nTremolanti C., Da Pozzo E., Giacomelli C., Costa B., Martini C. TSPO e regolazione dei processi neuroinfiammatori. Di nuovo TUM: Mappatura interregionale delle tematiche SIB tra Toscana, Umbria e Marche. 2019, June 11, Ancona, Italy.\nTremolanti C., Da Pozzo E., Giacomelli C., Martini C., Costa B. Translocator Protein (TSPO, 18 kDa) in neuroinflammation: investigation of its functional role in primary human microglia. XIX Congresso Nazionale AIBG \u2013 Associazione Italiana di Biologia e Genetica Generale e Molecolare. 2019, October 4-5, Milano, Italy.\nPoster communications at congress\n:\nTremolanti C., Giacomelli C., Cavallini C., Martini C., Da Pozzo E. Sex differences in hypertension: in vitro studies. International Meeting Steroids and Nervous System. 2019, February 16-20, Torino, Italy.\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "rkafdo5tvN", "title": "Erica Zucchetti - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/1999-2/", "lang": "en", "text": "Erica Zucchetti - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nErica Zucchetti\nErica Zucchetti\nContacts\n:\nTel: 0502219665\ne-mail:\nerica.zucchetti@phd.unipi.it\nSupervisor\n:\nProf.ssa Susi Burgalassi\nPhD project Title\n: Design and validation of reconstituted tissues for testing efficacy of pharmaceutical formulations\nResearch summary\n:\nThe aim of the project is to develop and/or improve\nin vitro\ncell-based assays for testing efficacy of pharmaceutical formulations and in particular the ultimate goal is to prepare reconstituted tissues from cell cultures, primary corneal models, similar to native tissues in order to predict the toxicity and permeation of the drugs, as well as reproduce possible diseases related to these areas to improve the understanding of processes that govern them and to study treatment options. The development of tissue models, in addition to simplifying experimentation in pharmaceutical technology, leads to replace, refine and reduce animal testing.\nPublications\n:\nPoster communications at congress\n:\nInteractions of new anticancer agents with biomembrane models: a calorimetric study \u2013 (Monti D., Tampucci S., Burgalassi S., Zucchetti E., Digiacomo M., Bertini S., Granchi C., Saccomanni G., Chetoni P.) \u201c4th conference on innovation in drug delivery: site-specific drug delivery\u201d in Antibes (France), 2016.\nPharmaceutical characterization of anticancer agents with innovative mechanism of action \u2013 (Digiacomo M., Bertini S., Manera C., Minutolo F., Granchi C., Saccomanni G., Zucchetti E., Monti D., Tampucci S., Burgalassi S., Chetoni P., Macchia M.) \u201c10th young medicinal chemist\u2019 symposium\u201d in Perugia (Italy) 2016.\nGellan Gum-based In-situ Gelling Systems containing Self-Assembling Mixed Nanomicelles: A Novel combined system for the Ocular Delivery of Cyclosporine-A \u2013 E. Terreni, E. Zucchetti, D. Monti, S. Burgalassi, S. Tampucci, P. Chetoni (2019).\u00a0\u201cNanomedicine International Conference and Exhibition 2019\u201d, International Conference, Lisbon, Portugal, October 22-25\nth\nGellan gum-based in situ gelling systems containing self-assembling nanomicelles for topical ocular delivery of cyclosporine-A \u2013 Terreni, E. Zucchetti, D. Monti, S. Burgalassi, S. Tampucci, P. Chetoni (2019).\u00a0\u201cNew challenging in self-assembling drug delivery systems\u201d, XIII A.It.U.N Annual Meeting, Relais Borgo Lanciano, Castelraimondo (MC), Italy, June 13-14\nth\n2019.\nReconstituted epithelial tissues and native cornea: A comparison of the influence of surfactants on ocular permeability \u2013 Zucchetti E., Monti D., Chetoni P., Tampucci S., Burgalassi S. \u00a0\u00a0\u201c2\u00b0 Annual Meeting 3Rs in Italian Universities\u201d, Genoa, 20-21 June 2019\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "j9CjY9mEAh", "title": "Lorenzo Flori - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/lorenzo-flori/", "lang": "en", "text": "Lorenzo Flori - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nLorenzo Flori\nLorenzo Flori\nContacts\n:\nTel: 050 2219529\ne-mail: lorenzo.flori@phd.unipi.it\nSupervisors\n:\nProf. Vincenzo Calderone\nPhD project Title\n:\nInflamm-aging: Pharmacological modulation of the \u201cH\n2\nS system\u201d for the treatment of age-related cardiovascular disorders.\nResearch summary\n:\nThe increase of global life expectancy in the last century is accompanied by a high incidence of age-related chronic diseases such as hypertension, myocardial infarction, cancer and diabetes. Hydrogen sulfide (H\n2\nS) plays a key role, expecially in cardiovascular aging, because it exerts a physiological cytoprotective activity. Unfortunately, the bioavailability of this endogenous gasotransmitter is reduced in age-related diseases, therefore the pharmacological modulation of the H\n2\nS system is an interesting strategy for the treatment of these pathological disorders.\nPublications\n:\nPoster communications at congress\n:\nFlori L., Piragine E., Martelli A., Citi V., Calderone V., Testai L. Ipoglycemic and anti-obesity effect of an\nEruca Sativa\nseeds extract in an experimental model of metabolic syndrome. VIII SYRP: S.I.FIT. YOUNG RESEARCHERS PROJECT \u201cExperimental models for the study of natural products\u201d. Imola, 14 Febbraio 2019.\nFlori L., Piragine E., Citi V., Martelli A., Pagnotta E., Ugolini L., Matteo R., Di Cesare Mannelli L., Lazzeri L., Ghelardini C., Calderone V., Testai L. Nutraceutical effects of an\nEruca Sativa\nseed extract in an experimental model of metabolic syndrome. Convegno monotematico SIF \u201cLe basi farmacologiche dei Nutraceutici\u201d. Napoli, 29-30 Marzo 2019.\nFlori L., Piragine E., Testai L., Citi V., Martelli A., Pirone A., Miragliotta V., Matteo R., Ugolini L., Pagnotta E., Lazzeri L., Di Cesare Mannelli L., Ghelardini C., Calderone V. Effects of a seed extract of Eruca Sativa Mill. in an experimental model of metabolic syndrome. 39\u00b0 Congresso nazionale SIF (Societ\u00e0 Italiana di Farmacologia). Firenze, 20-23 Novembre 2019.\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "SWoYPCSYzi", "title": "Vibhu Jha - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/vibhu-jha/", "lang": "en", "text": "Vibhu Jha - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nVibhu Jha\nVibhu Jha\nContacts\n:\nTel: +39-3913821437, +91-9981346205\ne-mail:\nvibhu.jha@farm.unipi.it\n,\nvibhujha16@gmail.com\nSupervisor\n:\nProf. Tiziano Tuccinardi\nPhD project Title\n:\nComputational approaches to identify small molecule modulators of new drug targets\nResearch summary\n:\nMy PhD research areas majorly involve computational drug discovery with an additional application of synthetic medicinal chemistry. I utilize in-silico guided approaches to identify new ligands as potential inhibitors of pharmacological target of our interest, with a great focus on investigation of anticancer hit compounds. I employ pharmacophore-based/ligand-based Virtual Screening (VS) procedures with of aid of molecular docking programs and post-docking refinement filters like Consensus Docking (CD) platform, Interaction-Fingerprints (IFP) and Molecular Dynamics (MD) simulations. The computational protocol also comprises of correct ligand-binding mode prediction and binding energetics studies to help in the hit identification and hit-lead optimisation workflow. First 17 months of my PhD (Nov. 2017- March 2019) were focussed on VS studies to identify hit inhibitors of following three important anticancer targets;\n[1] Lactate dehydrogenase-A (LDH-A)\n[2] Mono-acyl glycerol lipase (MAGL)\n[3] StAR related lipid transfer domain containing 3 (STARD3)\nThe active compounds identified after enzyme assay were utilized for the improvement of previous VS study or subjected to synthetic optimisation by collaborative research groups.\nFrom April-Sept 2019, I carried out synthetic medicinal chemistry project at Institute of Cancer Therapeutics (ICT), University of Braford, UK as a visiting PhD student under the supervision of Prof. Klaus Pors (Senior Lecturer, Chemical Biology). I was involved in design, synthesis, molecular docking and fluorescence tracking of Hypoxia-Activated Prodrugs (HAPs) as DNA intercalators against cancer cells. The synthesized compounds were tested against various cancer cell lines, active compounds were subjected to synthetic optimisation in order to lengthen the library of compounds. Compounds with notable fluorescence were further explored for clinical biomarker application.\nUtilizing significant learning aspects from both computational drug discovery and synthetic medicinal chemistry research, remaining part of my PhD will be focussed on VS and medicinal chemistry projects for hit identification/hit-lead optimization of new and unexplored important biological targets.\nPublications\n:\nPoster communications at congress\n:\nJha V., Tuccinardi T., Granchi C., Minutolo F. Virtual screening platform on structure-based pharmacophore hypothesis to identify potential human LDH-A inhibitors against cancer. Italian-Spanish-Portuguese Joint Meeting in Medicinal Chemistry, MedChemSicily, University of Palermo, 2018, July17-20, Palermo, Italy.\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "VLEPDeHvux", "title": "Francesca Liva - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/francesca-liva/", "lang": "en", "text": "Francesca Liva - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nFrancesca Liva\nFrancesca Liva\nContacts\n:\nTel:\u00a0 0502219500\ne-mail: francescaliva93@gmail.com\nSupervisors\n:\nProf. \u00a0Armando Rossello\nPhD project Title\n:\nBioengineered in vitro models of human tissues and drug design and development\nResearch summary\n:\nThis project aims at designing and validating an outer blood-retinal-barrier (oBRB) on-a-chip to encourage the development of innovative treatments for retinal degenerative diseases, such as Age-related Macular Degeneration (AMD). In particular, this project\u00a0 exploits recent discoveries in micro and nanotechnology in order to: i ) develop and optimise a biotechnological model of the Bruch\u2019s membrane (BrM) by using selected biomaterials resembling the biochemical and topological cues of the interface between\nRetinal Pigment Epithelium\n(\nRPE\n) layer and vascular network. The membrane facing the RPE will be assembled using an electrospinning system able to produce an unwoven structure made of fibers with nanometers resolution and a well defined porosity at micro and nanometers scale, able to mimic the extracellular matrix topology, which affects the permeability of this cell-free barrier; ii ) assemble a bioengineered\nin vitro\nmodel able to reproduce cell crosstalk between these eye structures. In particular, in order to mimic the cellular environment of oBRB, RPE cells will be cultivated over the BrM layer; iii ) define a novel biotechnological and commercial benchmark for a more rapid, low cost and customizable drug testing for visual disturbances. Such structure will be used to test the permeability and safety of novel drug candidates as well as to study their impact on retinal cells in physiological and pathological (AMD) conditions; iv) use these biomaterials as novel therapeutic implants for the cure of eye diseases. This\nin vitro\n3D model can \u00a0reproduce the metabolic and functional properties of human cells\nin vivo\n.\nPublications\n:\nPoster communications at congress\n:\nLiva F\na\n,\nDe Acutis A\nb\n, Montemurro F\nb\n, De Maria C\nb\n, , Cuffaro D\na\n,\nNuti E\na\n,\nOrlandini E\na\n,\nRossello A\na\n,\nVozzi G\nb\n.\nFabrication and characterization of a biotechnological Bruch\u2019s membrane for RPE\nin vitro\nmodel. Conference of the Division of Biological Systems Chemistry\u201d Siena , 11-13 September 2019. Book of Abstracts: pag 53.\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "ULjgG4W938", "title": "Angelica Mero - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/angelica-mero/", "lang": "en", "text": "Angelica Mero - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nAngelica Mero\nAngelica Mero\nContacts\n:\nTel: 0502219500\ne-mail:\nangelica.mero@phd.unipi.it\nSupervisors\n:\nProf. Christian Silvio Pomelli, Dott.ssa Felicia D\u2019Andrea\nphD project Title\n:\nValorisation of biomass waste by a combined used of ionic liquids (ILs) and deep eutectic solvents (DESs)\nResearch summary\n:\nThe main aim of my PhD work is to develop a safe multi-stage strategy to fully valorise biomass waste (i.e. chestnut shells, etc\u2026), in order to reduce the high amount of waste to be disposed and at the same time to find new necessary renewable resources due to the increasing demand for chemicals and fuels. More in details, this valorization will be performed through the extraction of high added value bioactive compounds (such as polyphenols, compounds that may help in the prevention of several diseases as they possess important biological properties such as anti-inflammatory, antiviral, analgesic, anticarcinogenic, antimicrobial (antifungal and antiviral) and antioxidant activities) or components with attractive biomedical application (such as cellulose, a natural polymer adaptable for wound dressing, medical implants, vascular graft, scaffolds for tissue engineering and drug delivery systems or lignin, phenolic macromolecule usable as renewable feedstock for sustainable production of aromatic chemicals). Moreover, the goal of the project is the employment of green solvents, like ionic liquids (ILs) and deep eutectic solvents (DES), as extracting medium. These solvents are considered valid green alternatives to organic solvents, that present inherent toxicity and high volatility.\u00a0 They also present unique suitable properties for extraction processes, including good solvent power towards organic, inorganic and polymeric compounds, high thermal and chemical stability, negligible vapour pressure, meanwhile offering easy containment, product recovery and recycling ability.\u00a0 In the work, particular attention will be given to sustainable ILs (defined Bio-ILs), composed by renewable and biocompatible compounds and to NADES (natural deep eutectic solvents) obtained by combining molecules abundantly present in nature.\nOral communications at congress\n:\n5\nth\nCentral and Eastern European Conference on Thermal Analysis and Calorimetry (CEEC-TAC) and 14\nth\nMediterranean Conference on Calorimetry and Thermal Analysis (Medicta2019), Roma, 27-30 agosto 2019. A. Mero, J. Gonz\u00e0les Rivera, E. Husanu, C. Ferrari, C. Duce, M. R. Tin\u00e8, C. S. Pomelli, L. Gazzelli. Thermoanalytical characterization and microwave heating response of deep eutectic solvents.\nILSEPT \u2013 4\nth\nInternational Conference on Ionic Liquids in Separation and Purification Technology, Sitges, 8-11 settembre 2019.A. Mero, J. Gonz\u00e0les Rivera, E. Husanu, L. Gazzelli, C. Chiappe. Valorisation of biomass waste by a combined use of ionic liquids (ILs) and deep eutectic solvents (DESs).\nPoster communications at congress\n:\nCFF2019 (Chemistry for the future International Conference), Pisa, 3-5 luglio 2019. A.Mero, E. Husanu, J. Gonz\u00e0les Rivera, L. Gazzelli, F. D\u2019Andrea, C. Pomelli, C. Chiappe. Valorisation of chestnut shells by a combined use of ionic liquids (ILs) and deep eutectic solvents (DESs).\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "LWsBhxcgzv", "title": "Nayla Mouawad - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/nayla-mouawad/", "lang": "en", "text": "Nayla Mouawad - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nNayla Mouawad\nNayla Mouawad\nContacts\n:\nTel: 3914039645\ne-mail:\nnaylabmouawad@gmail.com\nSupervisors\n:\nProf. Tiziano Tuccinardi\nPhD project Title\n:\nNew molecular targets for cancer therapy\nResearch summary\n:\nCRC is a leading cause of cancer-related deaths worldwide. Resistance to targeted therapies is the major limit. New therapeutic opportunities to treat CRC patients are required especially in metastatic tumors. A molecular characterization by The Cancer Genome Atlas could be useful in these tumor subtypes to reveal new candidate genes that can be inhibited. Our research group identified SPATS1 (Spermatogenesis-associated serine-rich 1) as amplified oncogene out of 214 candidates. SPATS1 is involved in spermatogenesis. We identified SPATS1 as amplified oncogene in CRC cell lines. We focused on the characterization of this protein that surprisingly showed the appearance of a second band that has a higher molecular weight than the predicted only in CRC cell lines suggesting that this higher band may be tumor specific. Alkaline phosphatase showed that this higher band could be due to hyperphosphorylation. Western blot and immunohistochemistry showed that SPATS1 is cytoplasmic but interestingly it mapped to nuclei as well in CRC. We also checked the expression of SPATS1 in Hek293T cells that have only the lower band corresponding to the predicted molecular weight of the protein to model the expression variation of the bands. In addition, we investigated that SPATS1 promotes CRC cell proliferation and tumorigenesis in 4 CRC cell lines: HCT116, HT29, DLD1, and LoVo. Our aim is to characterize SPATS1 protein and understand its mechanism of action in CRC in vitro and ex vivo. Finally, we want to design and validate SPATS1 inhibitors in CRC models.\nPublications:\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "7KdieqRNCX", "title": "Eugenia Piragine - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/eugenia-piragine/", "lang": "en", "text": "Eugenia Piragine - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nEugenia Piragine\nEugenia Piragine\nContacts\n:\nTel: 0502219500\ne-mail:\neugenia.piragine@farm.unipi.it\nSupervisors\n:\nProf. Vincenzo Calderone\nPhD project Title\n:\nPharmacological modulation of signalling pathways involved in ageing and inflamm-ageing.\nResearch summary\n:\nIn the last decades, the average lifespan has progressively increased worldwide. Ageing represents a dramatic risk factor for the development of several age-related cardiovascular disorders (i.e. hypertension, myocardial infarction and vascular inflamm-ageing). Nevertheless, how biological ageing itself influences the development of chronic diseases is still unclear; therefore, understanding the fundamental mechanisms of the ageing process is essential to reduce the onset of age-related pathologies, highlighting the concept of \u201chealthy ageing\u201d. In this context, the identification of novel anti-ageing agents represents a timely challenge. This project is focused on the investigation of the pharmacological effects of naturally occurring compounds against cardiovascular ageing both\nin vitro\nand\nin vivo\n. Specifically, the evaluation of the biological effects of polyphenols and isothiocyanates (H\n2\nS-donors) with a high translational potential in the clinical practice represents the main topic of this research.\nPublications\n:\nOral communications at congresses:\nPiragine E, Martelli A, Citi V, Testai L, Brancaleone V, Bucci M, Pagnotta E, Lazzeri L, Calderone V.\nErucin, a natural isothiocyanate from Eruca sativa Mill., protects vascular cells from oxidative stress and inflammation by release of H\n2\nS\n. International School of Pharmacology \u201cGiampaolo Velo\u201d \u2013 new strategies in the prevention of non-communicable diseases: focus on cardiovascular and metabolic disorders, Erice (Sicily), September 8-12, 2019.\nPiragine E, Testai L, Martelli A, Citi V, Flori L, Piano I, Gargini MC, Pirone A, Miragliotta V, Di Cesare Mannelli L, Ghelardini C, Breschi MC, Calderone V.\nThe Citrus flavonoid Naringenin prevents cardiac ageing via modulation of SIRT1.\nXXVI National Congress of the Italian Society of Phytotherapy (SIFit.), May 24-26, 2019.\nPiragine E, Citi V, Testai L, Breschi MC, Pagnotta E, Lazzeri L, Ugolini L, Calderone V, Martelli A.\nVasorelaxing and antihypertensive properties of Erucin, an isothiocyanate from Eruca sativa Mill, (Brassicaceae): is H\n2\nS the silent player?\nXXI SIF Seminar for PhD Students, Fellows, Post Doc and Specialist Trainees, Bresso (MI), September 19-22, 2018.\nPiragine E, Citi V, Testai L, Pagnotta E, Lazzeri L, Ugolini L, Calderone V, Martelli A.\nAntioxidant and cytoprotective effects of Erucin against H\n2\nO\n2\nand high glucose induced cell damages on vascular cell lines: is H\n2\nS the real player?\nXXVI Congresso nazionale di Fitoterapia, Fiuggi, May 25-27, 2018.\nPoster communications at congresses:\nPiragine E, Testai L, Martelli A, Citi V, Flori L, Piano I, Gargini MC, Pirone A, Miragliotta V, Di Cesare Mannelli L, Ghelardini C, Breschi MC, Calderone V. The Citrus flavonoid Naringenin slows down myocardial ageing by increasing sirtuin 1 enzyme expression in mice. 39\u00b0 National Congress SIF (Italian Society of Pharmacology), Firenze, 19-23 November, 2019 (Accepted).\nPiragine E, Martelli A, Citi V, Testai L, Brancaleone V, Vellecco V, Bucci M, Pagnotta E, Ugolini L, Lazzeri L, Calderone V.\nThe H\n2\nS-donor Erucin, a natural isothiocyanate from Eruca sativa Mill., protects vascular cells against oxidative stress and inflammation.\nXXII National Congress SIRC (Italian Society of Cardiovascular Researchers), Imola, 6-8 November, 2019 (Accepted).\nPiragine E, Piano I, Martelli A, Citi V, Gargini MC, Breschi MC, Calderone V, Testai L.\nMyocardial anti-ageing effects of the Citrus flavonoid naringenin.\n38\u00b0 National Congress SIF (Italian Society of Pharmacology), Rimini, October 24-28, 2017.\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "SoutK3ZEbp", "title": "Arianna Mancini - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/arianna-mancini/", "lang": "en", "text": "Arianna Mancini - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nArianna Mancini\nArianna Mancini\nContacts\n:\nTel: 0039 3283512110\ne-mail:\narianna.mancini3@gmail.com\nSupervisors\n:\nProf. Elena Dreassi; Prof. Tiziano Tuccinardi\nPhD project Title\n:\nIn vivo\nMRI evaluation of pharmacokinetics and biodistribution of new pyrazolo[3,4-\nd\n]pyrimidine derivatives delivered by targeted liposomes\nResearch summary\n:\nThis Ph.D. project includes the preclinical development and characterization of novel pyrazolo[3,4-\nd\n]pyrimidine-structure based anticancer agents, identified as potent tyrosine kinase inhibitors. Some members of this family showed a good activity against two nervous system cancers, neuroblastoma and glioblastoma. These compounds could represent a new and improved step toward targeted nervous system cancer therapy, that has the potential for avoiding some of the drawbacks associated with cytotoxic chemotherapy. The most promising compounds are selected, formulated, and characterized for their pharmacokinetic, toxicological and pharmacodynamic properties both\nin vitro\nand\nin vivo\n. First, properties such as aqueous solubility, permeability and metabolic stability, plasma protein binding are assessed, then the inhibitory properties of drugs on cytochrome P450 enzymes, hERG channel and P-glycoprotein are evaluated. By means of pharmacokinetic tests in healthy mice, important parameters such as plasma half-life, clearance, oral bioavailability and brain penetration are estimated. Formulation studies comprises the development of long circulating nano-systems for their use against solid cancers. Liposomes are essential tools in drug delivery, tumor targeting and molecular imaging. Exploiting the possibility of engineering liposomes surface to make them specific for tumor cells, the project includes the preparation of pyrazolo[3,4-\nd\n]pyrimidines-loaded liposomes coupled with the antibody anti-disialoganglioside-2 (anti-GD-2), with the aim of targeting its epitope, which is abundantly expressed at neuroblastoma cells surface. Liposomes coupled with anti-GD2 can improve drug delivery and cellular uptake, enhancing the efficacy of the drug toward experimental models of human neuroblastoma. In addition, liposomes could be an effective platform for MRI contrast agent to allow that distribution and drug release can be fully visualized using molecular imaging. In order to make liposomes MRI-sensitive, they are co-loaded with the anticancer compound and contrast agent Gd-DTPA, thus making them observable in MR images.\nPublications\n:\nPoster communications at congress\n:\nMancini, A.; Fallacara, A. L.; Zamperini, C.; Iovenitti, G.; Rango, E.; Angelucci, A.; Schenone, S.; Botta, M. Preclinical Development of Novel Pyrazolo[3,4-d]Pyrimidine Structure-Based TKIs for the Treatment of Glioblastoma. AACR Annual Meeting. 2019 March 29, Atlanta, Georgia, USA. (https://www.abstractsonline.com/pp8/#!/6812/presentation/5462)\nMancini, A.; Iovenitti, G.; Zamperini, C.; Calandro, P.; Schenone, S.; Botta, M. Plasmin-Binding Tripeptide-Decorated Liposomes Loading Pyrazolo[3,4-d]Pyrimidines for Targeting Hepatocellular Carcinoma. European Workshop in Drug Synthesis. 2018 May 20, Siena, Italy.\nMancini, A.; Iovenitti, G.; Vignaroli, G.; Calandro, P.; Zamperini, C.; Coniglio, F.; Tavanti, M.; Colecchia, D.; Dreassi, E.; Valoti, M.; Schenone, S.; Chiariello, M.; Botta, M. Improvement of Pyrazolo[3,4-d]Pyrimidines Pharmacokinetic Properties: Nanosystem Approaches for Drug Delivery. 13th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology. 2017 July 24, Rome, Italy.\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "V4eusiSQNC", "title": "Lucrezia Margherita Comparini - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/lucrezia-margherita-comparini/", "lang": "en", "text": "Lucrezia Margherita Comparini - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nLucrezia Margherita Comparini\nLucrezia Margherita Comparini\nName:\nLucrezia Margherita Comparini\nContacts\n:\nPhone: 050 221 9692\ne-mail: lucrezia.comparini\n@\nphd.unipi.it\nSupervisors\n: Mauro Pineschi\nPh.D. project Title\n: Development of new small molecules targeting GLP-1 secretion.\nResearch summary\n: GLP-1 is an incretin hormone released by intestinal L-cells mostly after food ingestion. Binding its receptor, GLP-1 enhances the secretion of insulin from pancreatic\nb\n-cells, reduces gastric emptying and food intake. This makes GLP-1 receptor an interesting target for diabetes treatment, moreover, GLP-1 agonists have been proven to be neuroprotective and neuro-regenerative agents. GLP-1 mimetic peptides are commercially available, but they present problems such as low stability and compliance, and various side effects. 1,3-diaza-4-oxa-[3,3,1]bicyclic scaffolds obtained in our lab with a four-step linear synthesis, being small molecules with the right physicochemical feature for an oral administration, are effective candidates to enhance GLP-1 secretion both\nin vitro\nand\nin vivo\n. The aim of this research project is the construction of a library of compounds having this scaffold, the evaluation of their antidiabetic and neuroprotective activity, and the study of the mechanism of action.\nORCID identifier:\n0000-0002-2259-3260\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "sHzPxBiTPa", "title": "Francesca Corsi - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/francesca-corsi/", "lang": "en", "text": "Francesca Corsi - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nFrancesca Corsi\nFrancesca Corsi\nName:\nFrancesca Corsi\nContacts\n:\nPhone: 0502229537\ne-mail: francesca.corsi@phd.unipi.it\nSupervisors\n:\nProf.ssa Maria Claudia Gargini\nPhD project Title\n:\nSaffron treatment as nutraceutical strategies for a mutation-independent approaches to slow down Retinitis Pigmentosa (RP)\nResearch summary\n:\nRetinitis Pigmentosa (RP) is a hereditary retinal dystrophy characterized by the progressive degeneration of photoreceptors and abnormalities in retinal pigment epithelium. The purpose of my PhD project is to fill a gap in current knowledge of RP by devising a still missing pharmacological treatment which exploits the ability of new molecules to target oxidative stress and delay the disease progression. In particular, I will study the efficacy of a treatment based on saffron and its natural and synthetic derivatives, in slowing down the progression of retinal degeneration in animal models of RP.\nOrcid id:\nhttps://orcid.org/0000-0002-9350-7948\nPoster communications at congress\n:\nCorsi F.\n, Piano I., Cerri C., Di Paolo M., Bisti S and Gargini C. \u201cElectrophysiological analysis of retinal function in a neurodegenerating animal model treated with nutraceutical molecules\u201d. Innovative Researches in Pharmaceutical and Environmental Sciences (IRPES) \u2013 Pisa 4 Dicembre 2020\nCorsi F.\n, Piano I., Polini B. and Gargini C. \u201cGenetic modulation of anti-oxidant nutraceutical molecules slows down retinal degeneration in a mouse model of Retinitis Pigmentosa\u201d. \u00a03rd Brainstorming Research Assembly for Young Neuroscientists (BRAYN) \u2013 Pisa 25-26 Novembre 2020\nCorsi F.\n, Piano I., Guazzelli L., D\u2019Andrea F., Sartini S., Giorgelli F., Confini G., Quattrini L., Nencetti S., Orlandini E., La Motta C. and Gargini C. \u201cDiabetic retinopathy: evaluation of the efficacy of new synthetic molecules in an in-vitro model of hyperglycemia\u201d Innovative Researches in Pharmaceutical and Environmental Sciences (IRPES) \u2013 Pisa 27 Novembre 2019\nPiano I.,\nCorsi F.\n, Biagioni M., Novelli E., Ghidoni R., Gargini C. and Strettoi E. \u201cPharmacological strategies to slow down cone death and vision loss in animal models of Retinitis Pigmentosa\u201d Institute of Neuroscience CNR (IN_CNR) Annual Retrat 2019 \u2013 Pisa 2-4 Ottobre 2019\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "N3ZGusfdMW", "title": "Lara Russo - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/lara-russo/", "lang": "en", "text": "Lara Russo - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nLara Russo\nLara Russo\nName:\nLara Russo\nContacts\n:\nPhone: 3270085566\ne-mail: lara.russo@phd.unipi.it\nSupervisors\n:\nProf. Maria Letizia Trincavelli, Dr. Chiara Giacomelli\nPhD project Title\n:\nMolecular mechanisms of cell differentiation in physio-pathological conditions\nResearch summary\n: (max 1000 crt, spazi inclusi)\nCell differentiation is the process in which cells acquire specific characteristics starting from a single type. Although differentiation mechanisms are already known, there is a need to obtain more knowledge about molecular pathways and how they are dysregulated in several diseases. An advancement of state of the art will be useful to approach new therapies for several diseases including cancer, neurodegenerative disease, and tissue damages.\nMy PhD project is then focalized mainly on two aspects of cell differentiation. On one hand, the effects of metal binding to neurotrophins as a regulator mechanism of neuron differentiation. On the other hand, the evaluation of mechanotransduction process and underlying signaling pathways that orchestrate the patient-derived mesenchymal stem cell differentiation in tenocytes to improve the creation of autologous tendon graft.\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "Hnm3C77ZBA", "title": "Paolo Caferra - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/dottorato-di-ricerca-in-scienza-del-farmaco-e-del-farmaco-e-delle-sostanze-bioattive/dottorandi/paolo-caferra/", "lang": "en", "text": "Paolo Caferra - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nDottorato di ricerca in Scienza del Farmaco e delle sostanze bioattive\nDottorandi\nPaolo Caferra\nPaolo Caferra\nName: Paolo Caferra\nContacts\n:\nPhone: +31 620 947 386\ne-mail: p.caferra@studenti.unipi.it\nSupervisors\n: Maria Letizia Trincavelli, Laura Marchetti\nPhD project Title\n: Strategies and their implementation throughout drug development form early to late stages\nResearch summary\n:\nPaolo Caferra is attending the PhD Program in \u201cScience of Drug and Bioactive Substances\u201d at University of Pisa. His research focuses on the description and analysis, from the regulatory affairs point of view, of the strategies employed by the company he is working for to develop investigational medicinal products through the drug development process, how the implementation of these strategies unfolds, and what are the feedbacks from the Health Authorities to these activities outcome. The results of this research will serve to originate a comprehensive overview of the drug development of his employer\u2019s assets which could be used to identify the features of successful strategic decisions, and be an example for the future development of other medicines. The drug development process of a ZFN gene editing technology for Sickle Cell Disease treatment, and an anti-C1s monoclonal antibody for multiple indications is going to be the focal point of his project.\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "KHeBti7KYA", "title": "Ricerca - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/ricerca/", "lang": "en", "text": "Ricerca - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nRicerca\nRicerca\nRESEARCH AREAS\nThe research at the Department of Pharmacy leads to scientific discovery obtained by funneling multidisciplinary biomedical, chemical and technological expertise towards the following research areas:\nDesign, chemical synthesis, sustainable approaches and analysis of molecules as therapeutic/diagnostic/theranostic agents.\nThe discovery and the characterization of new molecules for therapeutic/diagnostic uses requires a proper mix of chemical and biological knowledge, which is combined with perspective medical applicability, thus representing a highly interdisciplinary field. Research at our department covers the various steps of this process, including molecular design, chemical synthesis and advanced analysis. Within this research line, the organic chemistry effort is multifaceted as it ranges from development of new reaction methodology to access biologically relevant heterocycles, glycoconjugates and glycomimetics, to the valorization of biomasses and exploitation of unconventional green solvents in an environmentally sustainable way, including a support by computational methods.\nDevelopment and characterization of pharmaceutical dosage forms.\nA proper formulation of bioactive compounds is of extreme importance for the promotion of any pharmacological treatment. The dosage form ensures the drug to be available for absorption through biological barriers and to achieve the expected therapeutic activity maintaining an adequate physical, chemical and microbial stability. The components of the Technological Research Groups have expertise in the development of\u00a0a variety of formulations mainly aimed at\u00a0i)\u00a0the design of soluble systems or nanocarriers (viscous solutions, nanoparticles, nanomicelles, liposomes) for the transport of drugs in ophthalmic, mucosal and oral fields and \u00a0ii) the assessment of the technological and biopharmaceutical properties of the innovative systems \u00a0through the use \u00a0of in vitro, ex vivo or in vivo models.\nIdentification of drug targets, mechanisms of action and pharmacological profiles of bioactive compounds.\nBiochemical, pharmacology, molecular and morpho-functional approaches are linked towards (i) the investigation of new molecular and genomic bases of diseases, (ii) the biological evaluation of new therapeutic agents and (iii) the discover of new pathological biomarkers or diagnostic/therapeutic targets. The research activity is primarily focused on the molecular mechanisms involved in the control of gene expression, differentiation, and cellular transformations in cancer, inflammaging, neurodegeneration, cardiovascular and ocular disease, through the in vitro and in vivo assay of biological activity of newly synthetic and natural compounds, as potential bioactive molecules. The successful of these projects is ensured by a multidisciplinary research activity sustained by different skills, from molecular biochemistry, cellular biology, pharmacology and physiology.\nDiscovery and analysis of natural health products.\nThe research on natural health products includes vitamins and minerals, botanicals (herbs and plant products), and substances that come from a natural source such as primary and secondary metabolites (phytochemicals) endowed with biological activities, aroma properties, and health benefit. The staff is involved in: -extraction, isolation and characterization of these natural products coming from medicinal, aromatic, industrial, food sources, and in vitro plant cultures; -aroma profile and essential oil analysis; -biological screening; -quality control of plants and derivatives.\nRicerca\nSperimentazione animale\nTariffari\nCommissione Ricerca\nProdotti chimici\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
{"doc_id": "QDCHRTLZVD", "title": "Research Areas - Dipartimento di Farmacia", "description": "", "url": "https://www.farm.unipi.it/research-areas/", "lang": "en", "text": "Research Areas - Dipartimento di Farmacia\nVai al contenuto\nDipartimento di Farmacia\nWebmail\nPolo1-SIA\nCerca\nCerca\nHome\nDipartimento\nDidattica\nCorsi di Laurea\nLauree Magistrali a Ciclo Unico\nLauree Triennali\nLauree Magistrali\nPost-Laurea\nRicerca\nRESEARCH AREAS\nTariffari\nProgetti di ricerca\nQualit\u00e0\nSportello Tutorato\nTerza Missione\nHome\nResearch Areas\nResearch Areas\nDesign, chemical synthesis, sustainable approaches and analysis of molecules as therapeutic/diagnostic/theranostic agents\nDevelopment and characterization of pharmaceutical dosage forms\nIdentification of drug targets, molecular mechanisms of action, pharmacological profiles of bioactive compounds and innovative DNA- and RNA-based therapies\nDiscovery and analysis of natural health products\nMEDICINAL CHEMISTRY\nORGANIC CHEMISTRY\nINORGANIC CHEMISTRY\nPHARMACEUTICAL TECHNOLOGY\nBIOCHEMISTRY\nMOLECULAR BIOLOGY\nPHARMACOLOGY\nPHYSIOLOGY\nPLANT SCIENCES\nUniversit\u00e0 di Pisa\nDipartimento di Farmacia\nVia Bonanno, 6 \u2013 56126 Pisa\nP.I. 00286820501\nC.F. 80003670504\nTel +39 050 221 9500\nFax +39 050 2210680\nPEC:\nfarmacia@pec.unipi.it\nDirettore:\nmaria.trincavelli@unipi.it\nSeg. Amministrativa:\nsandra.masi@unipi.it\nSeg. didattica:\nsandro.bernacchi@farm.unipi.it\n\u00a9 2024\nDipartimento di Farmacia\nTorna in cima"}
